Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Human Insulin-like Growth Factor I (rhIGF-I) for the Treatment of Amyotrophic Lateral Sclerosis/motor Neuron Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/repview. Accessed 02 May 2024.
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/repview. Accessed May 2, 2024.
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/repview
Recombinant Human Insulin-like Growth Factor I (rhIGF-I) for the Treatment of Amyotrophic Lateral Sclerosis/motor Neuron Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review
ID - 431249
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431249/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -